MARK E REED MD NPI 1477585347

NPI Details

Mark E Reed, MD is a gynecologic oncology obstetrics gynecology in Germantown, TN with 39 years of experience. The provider is an obstetrician/gynecologist who provides consultation and comprehensive management of patients with gynecologic cancer, including those diagnostic and therapeutic procedures necessary for the total care of the patient with gynecologic cancer and resulting complications. Mark E Reed, MD NPI is 1477585347. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: UNIVERSITY OF TENNESSEE, HSC, COLLEGE OF MEDICINE
Graduation Year:1987

The provider's business location address is:

7945 WOLF RIVER BLVD
GERMANTOWN, TN
ZIP 38138-762
Phone: (901) 683-0055
Fax: (901) 685-9718

The NPI 1477585347 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, ferric carboxymaltose, 1 mg (HCPCS:J1439)
• Injection, darbepoetin alfa, 1 microgram (non-esrd use) (HCPCS:J0881)
• Injection, pembrolizumab, 1 mg (HCPCS:J9271)
• Injection, nivolumab, 1 mg (HCPCS:J9299)
• Injection, paclitaxel, 1 mg (HCPCS:J9267)
• Injection, oxaliplatin, 0.5 mg (HCPCS:J9263)
• Injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mg (HCPCS:Q5107)
• Injection, paclitaxel protein-bound particles, 1 mg (HCPCS:J9264)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Injection, daratumumab, 10 mg and hyaluronidase-fihj (HCPCS:J9144)
• Injection, azacitidine, 1 mg (HCPCS:J9025)
• Injection, carfilzomib, 1 mg (HCPCS:J9047)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Injection, docetaxel, 1 mg (HCPCS:J9171)
• Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg (HCPCS:J1568)
• Injection, bortezomib (velcade), 0.1 mg (HCPCS:J9041)
• Injection, trastuzumab-anns, biosimilar, (kanjinti), 10 mg (HCPCS:Q5117)
• Injection, pegfilgrastim, excludes biosimilar, 0.5 mg (HCPCS:J2506)
• Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Injection, fulvestrant, 25 mg (HCPCS:J9395)
• Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
• Injection, leucovorin calcium, per 50 mg (HCPCS:J0640)
• Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
• Liver function blood test panel (HCPCS:80076)
• Injection, ondansetron hydrochloride, per 1 mg (HCPCS:J2405)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Injection, fluorouracil, 500 mg (HCPCS:J9190)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 125 (HCPCS:86304)
• Injection, carboplatin, 50 mg (HCPCS:J9045)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Injection, potassium chloride, per 2 meq (HCPCS:J3480)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Unclassified drugs (HCPCS:J3490)
• Injection, magnesium sulfate, per 500 mg (HCPCS:J3475)
• Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg (HCPCS:J9201)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Automated urinalysis test (HCPCS:81003)
• Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month (HCPCS:99490)
• Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a (HCPCS:G9678)
• Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
• Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
• Manual urinalysis test with examination using microscope, automated (HCPCS:81001)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Injection, methylprednisolone sodium succinate, up to 125 mg (HCPCS:J2930)
• Magnesium level (HCPCS:83735)
• Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
• Therapy procedure using manual technique, each 15 minutes (HCPCS:97140)
• Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
• Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
• Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion (HCPCS:96368)
• Injection, zoledronic acid, 1 mg (HCPCS:J3489)
• Injection, fosnetupitant 235 mg and palonosetron 0.25 mg (HCPCS:J1454)
• New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
• Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
• Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
• Leuprolide acetate (for depot suspension), 7.5 mg (HCPCS:J9217)
• Stool analysis for blood to screen for colon tumors (HCPCS:82270)
• Infusion into a vein for hydration, each additional hour (HCPCS:96361)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l (HCPCS:G0498)
• Removal of uterus, tubes, and/or ovaries through abdomen using an endoscope, 250.0 g or less (HCPCS:58571)
• Blood creatinine level (HCPCS:82565)
• Therapy procedure using exercise to develop strength, endurance, range of motion, and flexibility, each 15 minutes (HCPCS:97110)
• Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
• Irrigation of implanted venous access drug delivery device (HCPCS:96523)
• Exam of external female genitals using an endoscope (HCPCS:56820)
• Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
• Imaging of lymph nodes during surgery (HCPCS:38900)
• Biopsy and removal of lymph nodes of abdominal cavity using an endoscope (HCPCS:38570)
• Blood test, clotting time (HCPCS:85610)
• Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
• Therapy procedure using functional activities (HCPCS:97530)
• Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
• Application of on-body injector for under skin injection (HCPCS:96377)
• Exam of vagina and cervix using an endoscope (HCPCS:57420)
• Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
• Ferritin (blood protein) level (HCPCS:82728)
• Training for self-care or home management, each 15 minutes (HCPCS:97535)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Administration of influenza virus vaccine (HCPCS:G0008)
• Iron level (HCPCS:83540)
• Iron binding capacity (HCPCS:83550)
• Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage (HCPCS:90694)
• Biopsy of lining of uterus (HCPCS:58100)
• Colonoscopy (HCPCS:NAN13)
• Melanoma (skin cancer) excision (HCPCS:NAN03)

The enumeration date for this NPI number is 7/7/2006 and was last updated on 1/25/2022.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.